HKT TRUST Aktie

 

In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855),please note that in the first paragraph of the release, the time should be 7:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 7:00 pm Hong Kong Time (HKT) and not 9 am EDT and 9 pm HKT as previously stated.The corrected release follows:...

ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that it will release its six months 2026 unaudited interim results and provide business updates at 9:00 am Eastern Daylight Time (EDT) on August 19, 2026 / 9:00 pm Hong Kong Time (HKT) on August 19, 2026....

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

HONG KONG (dpa-AFX) - Wednesday, HKT Trust and HKT Limited (HKTTY.PK) announced their financial results for the six months ended 30 June 2026. Profit for the period totaled HK$2,386 million, or 28......

HKT-SS (06823.HK) announced its interim results for the six months ended June 2026. Revenue rose 7.9% YoY to HKD18.685 billion. Net profit increased 4% YoY to HKD2.153 billion, with EPS at HKD0.2841. The company declared an interim dividend of HKD0.348, compared with HKD0.338 in the same period last year.During the period, EBITD......

HKT-SS (06823.HK) announced that Now TV has once again secured exclusive broadcasting rights for the English Premier League and the FA Cup for three seasons through the 2030/31 season.Now TV will continue to broadcast all 380 Premier League matches each season. Starting from the first round in Nov this year, Now TV will also bro......

- Company to host conference call and webcast on August 6, 2026, at 8:00 a.m. ET (8:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its second quarter 2026 financial results and provide recent corporate updates on August 6, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT). Conference Call and Webcast Information The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows: Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/4mhmttj2 Registration link for dial-in: https://register-conf.media-server.com/register/BIc69829b23daf4513a56e2253eaff583c All participants must use the link provided above to complete the online registration process in advance of the conference call...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2026 on Thursday, July 30, 2026 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT)....

HKT-SS (06823.HK) Chairman Richard Li said at the AGM that past crisis such as the SARS outbreak had only a mild impact on the Group's profit. While the current situation in the Middle East has indeed affected global energy markets, the extent of the impact will depend on how long the war lasts. Overall, he remains fully con......

- Company to host conference call and webcast on May 7, 2026, at 8:00 a.m. ET (8:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its first quarter 2026 financial results and provide recent corporate updates on May 7, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT). Conference Call and Webcast Information The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows: Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/s7q4ox5h Registration link for dial-in: https://register-conf.media-server.com/register/BI802954894429400baf012f775762af29 All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-...

HKT-SS (06823.HK) signed a Memorandum of Understanding (MoU) with the Hong Kong Applied Science and Technology Research Institute (ASTRI) to set up a joint research and development (R&D) laboratory at Hong Kong-Shenzhen Innovation and Technology Park (HSITP) in the Lok Ma Chau Loop. Leveraging its strengths in fiber-optic an......

US Central Command stated that it will start blocking all maritime traffic to and from Iranian ports at 10:00 am Eastern Time on April 13 (10:00 pm HKT on April 13). Earlier, US President Donald Trump said that the US Navy would begin blocking the Strait of Hormuz after peace talks between the US and Iran failed. International o......

The Hong Kong Monetary Authority (HKMA) has granted stablecoin issuer licenses to Anchorpoint Financial, a subsidiary of Standard Chartered Bank, and HSBC. Anchorpoint Financial is a joint venture established by Standard Chartered Bank, Animoca Brands and HKT-SS (06823.HK). Anchorpoint Financial expects to issue its regulated HK......

Advancing HBV Functional Cure Toward Key Phase 2b Data Readouts Increasing Discovery Efforts to Drive Long-term Value Creation Strong Cash Position Supporting Strategic Priorities Upcoming Conference Calls: English Session: March 20 at 8:30 p.m. HKT / 8:30 a.m. ET Chinese Session: March......

ROCKVILLE, Md. and SUZHOU, China, March 11, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in discovering, developing and commercializing novel, differentiated therapies to address unmet medical needs in cancer, today reported it will release its full year 2025 unaudited results and provide business updates at 7:00 pm Eastern Daylight Time (EDT) on March 25, 2026 / 7:00 am Hong Kong Time (HKT) on March 26, 2026....

Stocks | Potential Upside from Target PricesAlibaba (BABA.US) | 17.8%CHALCO (601600.SH) | +20.7%CATL (300750.SZ) | 33.3%DUALITYBIO-B (09606.HK) | 41.8%ESPRESSIF (688018.SH)| 30.7%HKEX (00388.HK) | 22%HKT-SS (06823.HK) | 7.1%NARI (600406.SH) | 0.9%PING AN (02318.HK) | 22.6%INOVANCE TECH (300124.SZ) | 25.7%SINOMA SCI & TECH (0......

– Total revenues grew 17% y-o-y to $127.6 million for the fourth quarter of 2025 and 15% y-o-y to $460.2 million for the full-year 2025 – Zocilurtatug pelitecan (zoci) on track to become Zai Lab's first global oncology launch, with three registration-enabling studies across 2L+ SCLC, 1L SCLC, and extrapulmonary NECs by the end of 2026 – Advancing a differentiated global pipeline, including ZL-1503 (IL-13/IL-31Rα), ZL-6201 (LRRC15 ADC), ZL-1222 (PD-1/IL-12) and ZL-1311 (MUC17/CD3 TCE) – Key regional programs continue to advance, with KarXT approved in China and commercial launch preparations underway; pivotal data readouts for povetacicept in IgAN and elegrobart in TED expected in 2026 Conference call and webcast today, February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the fourth quarter and full-year 2025, along with recent product highlights and corporate updates. “20...

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

- Company to host conference call and webcast on February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its fourth quarter and full year 2025 financial results and provide recent corporate updates on February 26, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (9:00 p.m. HKT). Conference Call and Webcast Information The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call. Details are as follows: Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/ftt8dzjp Registration link for dial-in: https://register-conf.media-server.com/register/BI3888301d591947ae8d0ccb041164c8e6 All participants must use the link provided above to complete the online registration process in advance of th...

The Group has made advance preparations for Hong Kong's accelerated pursuit of sci-tech self-reliance and self-strengthening at higher levels, Susanna Hui, Managing Director of HKT-SS (06823.HK), said. The Group recently established a new AI facility and R&D center in the Lok Ma Chau Loop, serving the Northern Metropolis......